Codes / ICD10CM / T65.5X3S

T65.5X3S Toxic effect of nitroglycerin and other nitric acids and esters, assault, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Effect of Nitroglycerin and Other Nitric Acids and Esters, Assault, Sequela

Summary

This condition describes residual or late effects of adverse health effects resulting from exposure to nitroglycerin or other nitric acids and esters due to assault. Sequela refers to complications or conditions that persist after the acute toxic episode, potentially affecting cardiovascular, neurological, or other systems long-term.

Causes

The toxic effect is caused by prior exposure to nitroglycerin or related nitric acids and esters as a result of assault, with sequela representing the lasting health consequences of that exposure. The original exposure may have occurred through ingestion, inhalation, or dermal contact, leading to acute toxicity that now manifests as chronic or residual effects.

Risk Factors

  • History of assault involving nitroglycerin or related compounds.
  • Severe acute toxicity during the initial exposure episode.
  • Delayed or inadequate treatment of the original toxic event.
  • Pre-existing health conditions that may worsen long-term outcomes.

Symptoms

  • Persistent hypotension or cardiovascular instability.
  • Chronic neurological deficits (e.g., cognitive impairment, seizures).
  • Ongoing gastrointestinal issues (e.g., recurrent nausea, abdominal pain).
  • Skin changes or scarring from dermal exposure.
  • Respiratory complications (e.g., chronic dyspnea, methemoglobinemia sequelae).

Diagnosis

Diagnosis is based on clinical evaluation of residual symptoms, a documented history of assault-related nitroglycerin exposure, and exclusion of other causes. Imaging or laboratory tests may be used to assess organ damage or functional deficits resulting from the original toxic event.

Treatment Options

Treatment focuses on managing chronic symptoms and preventing further complications. This may include ongoing cardiovascular monitoring, neurological rehabilitation, or symptomatic care for persistent organ dysfunction. The approach is tailored to the specific sequela and patient needs.

Prognosis and Follow-Up

Prognosis depends on the severity of the original toxicity and the extent of residual damage. Regular follow-up is essential to monitor for worsening symptoms, adjust treatments, and address any new complications. Long-term outcomes vary based on individual factors and the nature of the sequela.

Complications

  • Chronic cardiovascular dysfunction (e.g., persistent hypotension).
  • Neurological impairment (e.g., cognitive decline, seizures).
  • Gastrointestinal disorders (e.g., chronic pain, malabsorption).
  • Respiratory issues (e.g., reduced lung function, recurrent infections).
  • Psychological effects (e.g., trauma-related disorders).

Lifestyle & Prevention

  • Adhere to prescribed treatments and follow-up care.
  • Avoid re-exposure to nitroglycerin or related substances.
  • Maintain a healthy lifestyle to support overall recovery.
  • Seek support for psychological impacts of the original assault.

When to Seek Professional Help

Consult a healthcare provider if new or worsening symptoms occur, such as severe dizziness, chest pain, difficulty breathing, or signs of organ dysfunction. Emergency care is needed for acute complications like syncope or seizures.

Tips for Medical Coders

Document the history of assault and nitroglycerin exposure clearly, as well as the specific sequela being treated. Ensure the code T65.5X3S is used only when the condition is a direct result of the original toxic effect and assault, with sequela explicitly noted. Verify that the sequela is not better classified under another code.

Book a walkthrough

T65.5X3S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.